(Q42997927)

English

Secondary structure of the amino-terminal region of HCV NS3 and virological response to pegylated interferon plus ribavirin therapy for chronic hepatitis C.

scientific article published in August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Secondary structure of the amino-terminal region of HCV NS3 and virological response to pegylated interferon plus ribavirin therapy for chronic hepatitis C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

13

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Mai Sanjo

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Takafumi Saito

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Rika Ishii

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yuko Nishise

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hiroaki Haga

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kazuo Okumoto

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Junitsu Ito

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hisayoshi Watanabe

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Koji Saito

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hitoshi Togashi

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kazuto Fukuda

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yasuharu Imai

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Lin Deng

14

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Ikuo Shoji

15

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hak Hotta

16

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sumio Kawata

17

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

82

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1364-1370

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Significance of serum ribavirin concentration in combination therapy of interferon and ribavirin for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Gene induction pathways mediated by distinct IRFs during viral infection.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Risk of hepatocellular carcinoma and secondary structure of hepatitis C virus (HCV) NS3 protein amino-terminus, in patients infected with HCV subtype 1b.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Correlation between secondary structure of an amino-terminal portion of the nonstructural protein 3 (NS3) of hepatitis C virus and development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Identification of Hepatitis C Virus (HCV) Subtype 1b Strains That Are Highly, or Only Weakly, Associated with Hepatocellular Carcinoma on the Basis of the Secondary Structure of an Amino-Terminal Portion of the HCV NS3 Protein

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Hepatitis C treatment update

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Critical point mutations for hepatitis C virus NS3 proteinase

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors

1 reference

https://api.crossref.org/works/10.1002%2FJMV.21818

21 January 2018

Identifiers

10.1002/JMV.21818

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42997927&oldid=1592211746"